Deep Learning innovation. Made possible.

Canon Medical CT enables Deep Learning Reconstruction, enhancing image IQ and clinical confidence

CT scanners designed for patient safety and satisfaction, with technology that meets your needs now and in the future.

Advanced technologies and ergonomics are standard on every configuration. State-of-the-art capabilities are readily available for scanning the widest range of patients—from pediatric to bariatric. Industry-leading, automated dose reduction capabilities improve patient safety and increase your quality of care.

Canon Medical Canon Medical is now introducing AiCE, the industry’s first Deep Learning image reconstruction technology. Based on Neural Networking, AiCE technology lifts Artificial Intelligence to a platform not yet achieved before.

Visit Canon Medical at RSNA 2018 to learn more about AiCE.

RSNA2018    Contact us

Remove the Workflow Challenges of MBIR

FIRST* Integrated
Making CT safer for patients FIRST is a new model based iterative reconstruction that can lower dose by up to 82.4% as compared to traditional filtered back projection methods.

*Optional on the Aquilion ONE ViSION Edition only

Learn more about FIRST


Canon Medical’s iterative reconstruction technology can be applied to all examinations resulting in dose reductions of up to 75 % in daily routine.

Learn more about AIDR 3D


PUREViSION Detector Technology


The PUREViSION detector with industry-leading 0.5 mm element size delivers razor-sharp, fully isotropic images in all planes. By making more efficient use of X-rays, the innovative PUREViSION detector produces 40% more light to the photodiode allowing you to minimise patient dose while improving image quality.

Find out more about PUREViSION Detector



An optimised beam spectrum based on PUREViSION Optics results in a better balance between image quality and dose.


Our Product Range


Complete Clinical Capability

Aquilion LIghtning 160

The Smarter Investment

Aquilion LB

Opening new dimensions

SHARE THIS! Email this to someoneTweet about this on TwitterShare on LinkedInShare on FacebookShare on Google+